Archive for May, 2010
Monday, May 31st, 2010
Generalized anxiety disorder (GAD) is a prevalent and impairing disorder, associated with extensive psychiatric and medical comorbidity and usually characterized by a chronic course. Different drugs have been investigated in GAD; among them are the following: 1) SSRIS: paroxetine, sertraline, fluvoxamine and escitalopram; 2) SNRI1S: venlafaxine; 3) benzodiaze pines (BZS): alprazolam, diazepam and lorazepam; 4) azapirones (AZAS): buspirone; 5) (more…)
Tags: analysis, anxiety, Disorder, effect, generalized, pharmacologic, size, treatments
Posted in Xanax | No Comments »
Monday, May 31st, 2010
CORK UNIVERSITY Hospital yesterday became the first hospital in the State outside of Dublin to declare itself a smoke-free zone following the introduction of a smoking ban for patients, visitors and staff on the hospital campus. (Source: The Irish Times – Health)
Posted in Drugs | No Comments »
Monday, May 31st, 2010
Background: Acute retinal necrosis (ARN) is a sight-threatening condition that results from the reactivation of a dormant herpes virus. This typically occurs in immunocompetent individuals ages 20-50. Initial complaints may include pain, decreased vision, and floaters. Clinical presentation includes focal peripheral areas of retinal necrosis that progress rapidly, occlusive vasculopathy and a marked inflammatory reaction in the vitreous and anterior chamber. Retinal detachment occurs in approximately 75% of patients and is a major cause of vision loss. Thirty-six percent of casesÃÂ are bilateral, and only 30% of patients achieve greaterÃÂ than 20/200 vision. Other vision-threatening complications include optic neuritis and central retinal artery occlusion. Treatment involves antiviral and an…
Posted in Drugs | No Comments »
Monday, May 31st, 2010
U.S. regulators on Thursday said warnings about the risk of sudden hearing loss l inked to drugs for impotence, including Viagra, Cialis, and Levitra, would be added to the drugs’ labels. Reuters Health Information (Source: Medscape Pharmacist Headlines)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Tags: Adding, Drug, Dysfunction, Erectile, hearing, Labels, loss, risk
Posted in Cialis, Levitra, VIAGRA | No Comments »
Monday, May 31st, 2010
Authors: A G Rabchevsky, S P Patel, H Duale, T S Lyttle, C R O’Dell & P H Kitzman (Source: Spinal Cord)
Posted in Drugs | No Comments »
Monday, May 31st, 2010
New teen smoking statistics show efforts to keep kids from taking up the habit have stalled, the Canadian Cancer Society said Monday. (Source: CTV Health)
Posted in Drugs | No Comments »
Monday, May 31st, 2010
Cigarette smokers frequently describe the anxiolytic and antidepressant effects of smoking, but evidence suggests that cigarette smoking may itself increase negative affect, so that the causal direction of this association remains unclear. Although increasingly sophisticated analyses of epidemiological data may help to answer this question, observational data can never unequivocally provide evidence of causation. Here we discuss the potential utility of genetic information in determining the causal basis of the relationship of cigarette smoking and depression. (Source: The British Journal of Psychiatry)
Posted in Drugs | No Comments »
Monday, May 31st, 2010
In the case of a 13-month-old boy who died, battery current set off a chemical reaction in the esophagus, burning through its wall and attacking the aorta. (Source: NYT Health)
Posted in Drugs | No Comments »
Monday, May 31st, 2010
PHILADELPHIA – The auditor who examines applications for common benefit fees in the diet drug multidistrict litigation reports that as of March 31, attorneys have spent more than 553,000 hours on common benefit work wi th a cumulative lodestar value of more than $156 million (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 12 03, Sheila Brown, et al. v. American Home Products Corp., No. (more…)
Tags: Auditor, Benefit, Billable, Common, Hours, Reports, Work
Posted in Phentermine | No Comments »
Monday, May 31st, 2010
This study assessed the potential pharmacokinetic interaction and safety/tolerability of taranaba nt and phentermine coadministration. This was a randomized, double-blind, 3-panel, fixed-sequence study in healthy participants. Panels A, B, and C evaluated the safety/tolerability of phentermine 15 mg coadministered with taranabant 0.5, 1, and 2 mg for 7 days (panel A) and 28 days (panels B and C). In panels A and C, phentermine 15 mg was administered (more…)
Tags: Agonist, Cannabinoid, CB1R, Healthy, Inverse, Novel, Participants, Pharmacokinetics, Phentermine, Receiving, Receptor, Safety, Taranabant, Tolerability
Posted in Phentermine | No Comments »